M
Masakazu Miura
Researcher at Mitsubishi
Publications - 34
Citations - 1880
Masakazu Miura is an academic researcher from Mitsubishi. The author has contributed to research in topics: Bone remodeling & Excretion. The author has an hindex of 16, co-authored 34 publications receiving 1832 citations. Previous affiliations of Masakazu Miura include Osaka City University.
Papers
More filters
Journal ArticleDOI
Vitamin K2 (Menatetrenone) Effectively Prevents Fractures and Sustains Lumbar Bone Mineral Density in Osteoporosis
TL;DR: It is suggested thatitamin K2 treatment effectively prevents the occurrence of new fractures, although the vitamin K2–treated group failed to increase in LBMD.
Journal ArticleDOI
FGF-23 in patients with end-stage renal disease on hemodialysis
Yasuo Imanishi,Masaaki Inaba,Kiyoshi Nakatsuka,Kyoko Nagasue,Senji Okuno,Asami Yoshihara,Masakazu Miura,Akimitsu Miyauchi,Keisuke Kobayashi,Takami Miki,Tetsuo Shoji,Eiji Ishimura,Yoshiki Nishizawa +12 more
TL;DR: Serum phosphate, calcium, and intact PTH could be regulators of FGF-23 levels in uremic patients on maintenance hemodialysis and may provide new insights into the pathophysiologic effects of F GF-23 on calcium-phosphate homeostasis.
Journal ArticleDOI
Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women
Akifumi Tokita,H Matsumoto,Nigel Alexander Morrison,T Tawa,Yuko Miura,K Fukamauchi,Naoki Mitsuhashi,M Irimoto,Shunji Yamamori,Masakazu Miura,T Watanabe,Yoshinori Kuwabara,Keijiro Yabuta,John A. Eisman +13 more
TL;DR: It is confirmed that VDR RFLPs affect bone mineral metabolism regardless of racial differences, and the VDR genotypes based on haplotype analysis should yield useful insights into the potential prevention of osteoporosis.
Journal ArticleDOI
Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure.
Junichiro James Kazama,Takashi Shigematsu,Kazuki Yano,Eisuke Tsuda,Masakazu Miura,Yoshiko Iwasaki,Yoshindo Kawaguchi,Fumitake Gejyo,Kiyoshi Kurokawa,Masafumi Fukagawa +9 more
TL;DR: It is suggested that OCIF accumulates in serum of patients with renal dysfunction, and may be a candidate uremic toxin responsible for the skeletal resistance to PTH seen in chronic renal failure.
Journal ArticleDOI
Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover.
Ryo Okazaki,Yasuo Totsuka,Kumiko Hamano,Miho Ajima,Masakazu Miura,Yoshiko Hirota,Keishi Hata,Seiji Fukumoto,Toshio Matsumoto +8 more
TL;DR: Metabolic improvement of poorly controlled NIDDM decreases bone turnover within a short period, and glycemic control may protect NID DM patients from bone loss.